CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Keryx Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kesin Pharma — — —
60
39% 		7/20/2026 View Intelligence
Kestrel Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Key Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Key Qumica SA de CV — — —
60
42% 		7/20/2026 View Intelligence
Keymed Biosciences Coltd — — —
60
36% 		7/17/2026 View Intelligence
Keyrus Biopharma 1 trials — —
60
36% 		7/17/2026 View Intelligence
Keystone Pharmacy — — —
60
36% 		7/17/2026 View Intelligence
Keythera Pharmaceuticals (australia) — — —
60
36% 		7/17/2026 View Intelligence
Kgs Pharmamate — — —
60
36% 		7/17/2026 View Intelligence
Kiadis Pharma 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kibow Pharma 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kimberly-Clark — — —
60
40% 		7/20/2026 View Intelligence
Kinaset Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kind Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kindex Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kinesis Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kinex Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kinfield — — —
60
41% 		7/20/2026 View Intelligence
King Bio — — —
60
42% 		7/20/2026 View Intelligence
King Pharmaceuticals Is Now A Wholly Owned Subsidiary Of Pfizer — — —
60
36% 		7/17/2026 View Intelligence
Kingsway Pharmaceuticals dba NFI — — —
60
40% 		7/20/2026 View Intelligence
Kiniksa Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kiniksa Pharmaceuticals (uk) 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kiniksa Pharmaceuticals International — — —
60
36% 		7/17/2026 View Intelligence
Kinnate Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Kinnov Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kinopharma — — —
60
36% 		7/17/2026 View Intelligence
Kinoteck Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kinoxis Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kintara Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kiomed Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kiora Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kira Pharmacenticals (us) — — —
60
36% 		7/17/2026 View Intelligence
Kirilys Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kirin Pharmaceutical (asia) — — —
60
36% 		7/17/2026 View Intelligence
Kiromic Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Kissei Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kite Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kite Pharma (a Gilead ) — — —
60
36% 		7/17/2026 View Intelligence
Kitov Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kitov Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kling Biotherapeutics — — —
60
36% 		7/17/2026 View Intelligence
Klus Pharma — — —
60
36% 		7/17/2026 View Intelligence
Knight Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Knight Therapeutics (usa) — — —
60
36% 		7/17/2026 View Intelligence
Knoa Pharma — — —
60
36% 		7/17/2026 View Intelligence
Knoll Pharmaceuticals Germany (now Abbott) — — —
60
36% 		7/17/2026 View Intelligence
Knopp Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Koco Life — — —
60
40% 		7/20/2026 View Intelligence
Showing 3251 - 3300 of 6,643 companies